GILDER GAGNON HOWE & CO LLC: EYE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILDER GAGNON HOWE & CO LLC on EYE, newest first. How the timeline and the estimate are built.
GILDER GAGNON HOWE & CO LLC held 0 EYE shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -106,255 shares
13F-HR 0001172661-26-003462 filed by GILDER GAGNON HOWE & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 106,255 sharesChange vs previous 13F -5,879 shares
0.03% of the 13F portfolio, value $2,752,005.
13F-HR 0001172661-26-002064 filed by GILDER GAGNON HOWE & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 112,134 sharesChange vs previous 13F -772 shares
0.03% of the 13F portfolio, value $2,895,300.
13F-HR 0001172661-26-000858 filed by GILDER GAGNON HOWE & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 112,906 sharesChange vs previous 13F +5,308 shares
0.03% of the 13F portfolio, value $3,295,726.
13F-HR 0001172661-25-004939 filed by GILDER GAGNON HOWE & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 107,598 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $2,475,830.
13F-HR 0001172661-25-003286 filed by GILDER GAGNON HOWE & CO LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).